CAL
THC icon

Capital Advisors Ltd’s Tenet Healthcare THC Stock Holding History

Capital Advisors Ltd’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68K Hold
361
– – 0.01% 466
2026
Q1 		$68K Buy
361
+358
+11,933% +$75.4K 0.01% 446
2025
Q4 		$0 Sell
3
-358
-99% -$72.3K ﹤0.01% 1571
2025
Q3 		$73K Hold
361
– – 0.01% 420
2025
Q2 		$64K Hold
361
– – 0.01% 425
2025
Q1 		$49K Hold
361
– – 0.01% 456
2024
Q4 		$46K Hold
361
– – 0.01% 471
2024
Q3 		$60K Hold
361
– – 0.01% 423
2024
Q2 		$48K Buy
361
+319
+760% +$38.4K 0.01% 449
2024
Q1 		$4K Hold
42
– – ﹤0.01% 939
2023
Q4 		$3K Hold
42
– – ﹤0.01% 969
2023
Q3 		$3K Sell
42
-3
-7% -$224 ﹤0.01% 962
2023
Q2 		$4K Buy
45
+3
+7% +$214 ﹤0.01% 910
2023
Q1 		$2K Buy
+42
New +$2.33K ﹤0.01% 941
2022
Q4 		– Sell
-13
Closed -$1K – 1637
2022
Q3 		$1K Buy
13
+7
+117% +$415 ﹤0.01% 1128
2022
Q2 		$0 Buy
+6
New +$418 ﹤0.01% 1317

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Capital Advisors Ltd's THC Position: Q2 2026 in Review

Capital Advisors Ltd held its Tenet Healthcare (THC) position steady in Q2 2026 at 361 shares worth $68K. The position accounts for 0.01% of the portfolio, ranked #466.

Capital Advisors Ltd first reported a position in THC in Q2 2022 and has held it in 16 quarters since. The position peaked at $73K in Q3 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Capital Advisors Ltd held 361 shares of Tenet Healthcare worth $68K as of Q2 2026.
  • Capital Advisors Ltd left its Tenet Healthcare share count unchanged in Q2 2026.
  • Tenet Healthcare made up 0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #466 holding.
  • Capital Advisors Ltd first reported a position in Tenet Healthcare in Q2 2022 and has held it in 16 quarters since.
  • Capital Advisors Ltd's Tenet Healthcare position peaked at $73K in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.